AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $368,000 | -66.5% | 513,292 | +5.6% | 0.02% | -61.5% |
Q4 2021 | $1,099,000 | -32.6% | 486,220 | -14.1% | 0.04% | -35.0% |
Q3 2021 | $1,630,000 | -22.2% | 566,026 | +2.4% | 0.06% | -20.0% |
Q2 2021 | $2,096,000 | +7.2% | 552,976 | -4.3% | 0.08% | +17.2% |
Q1 2021 | $1,956,000 | -54.8% | 577,972 | -62.6% | 0.06% | -57.9% |
Q4 2020 | $4,329,000 | +9.2% | 1,546,169 | -2.1% | 0.15% | -5.0% |
Q3 2020 | $3,963,000 | -78.7% | 1,579,079 | +15.0% | 0.16% | -80.0% |
Q2 2020 | $18,644,000 | +74.8% | 1,372,888 | -2.4% | 0.80% | +34.2% |
Q1 2020 | $10,666,000 | +20.7% | 1,407,164 | +0.6% | 0.60% | +99.3% |
Q4 2019 | $8,839,000 | +51.9% | 1,398,621 | -5.8% | 0.30% | +43.8% |
Q3 2019 | $5,818,000 | -19.5% | 1,484,137 | -0.7% | 0.21% | -13.3% |
Q2 2019 | $7,231,000 | -42.9% | 1,494,070 | -3.3% | 0.24% | -41.2% |
Q1 2019 | $12,659,000 | +87.4% | 1,545,682 | +26.5% | 0.41% | +65.9% |
Q4 2018 | $6,755,000 | +1802.8% | 1,221,498 | +2937.0% | 0.25% | +1792.3% |
Q3 2018 | $355,000 | – | 40,220 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
Anson Funds Management LP | 95,342 | $267,000 | 0.05% |